Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Mural Oncology is leveraging its novel protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. Our lead candidate, nemvaleukin alfa, is currently in ...
Compugen: Immuno-Oncology Innovator Poised For A Comeback
Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...
eLife1d
Synovial macrophage diversity and activation of M-CSF signaling in post-traumatic osteoarthritis
Joint injury induces rapid and sustained diversification of resident and infiltrating synovial macrophage phenotypes, underpinning osteoarthritis-associated synovitis.
News Medical5d
New insight into gut stem cell aging
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...
Safeguarding intestinal stem cells during aging through balanced signaling
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...
The EMBO Journal6d
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4
Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...